Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients

Gynecologic Oncology
K BodnerK Mayerhofer

Abstract

The aim of this study was to evaluate the behavior of endometrial stromal sarcomas (ESS) in relation to their clinical and pathologic features and to identify possible prognostic factors. Thirty-one patients with histologically proven ESS were included in the analysis. Endometrial stromal sarcoma is characterized by proliferations composed of cells with endometrial stromal cell differentiation. A breakpoint of 10 mitoses per 10 high-power fields was used in the statistical analysis to distinguish between low-grade and high-grade endometrial stromal sarcoma and to evaluate the prognostic value of mitotic count in patients with ESS. The median follow-up time was 72 months (range 34-110). The median overall survival of the 31 patients was 127 months, resulting in a 5-year overall survival rate of 62%. Adjuvant therapy was administered to 25 patients; among those, 20 patients received postoperative radiotherapy and 5 patients received chemotherapy. Ten of the irradiated patients and 3 patients undergoing chemotherapy developed disease recurrence. Concerning the response rate to adjuvant chemotherapy, 1 patient showed a complete response, 1 patient a partial response, 1 patient stable disease, and 2 patients progressive disease. Alt...Continue Reading

Citations

Aug 10, 2006·World Journal of Surgical Oncology·Tahereh Ashraf-GanjoeiAsamosadat Mosavi
Jul 4, 2012·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Geetha Puliyath, M Krishnan Nair
Mar 1, 2008·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Eun Ji NamSang Wun Kim
Mar 18, 2003·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Janio SzklarukVithya Varavithya
Dec 1, 2012·Case Reports in Obstetrics and Gynecology·Olga CarameloIsabel Torgal
Apr 20, 2013·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Gabriel G MaloufPatricia Pautier
Jun 25, 2014·Archives of Gynecology and Obstetrics·Iván RíosAlbert Biete
Jul 1, 2005·Seminars in Ultrasound, CT, and MR·Catherine DevineEric P Tamm
Mar 17, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Izaskun ValduviecoAlbert Biete
Feb 27, 2004·Gynecologic Oncology·Yusuke MatsuuraMasamichi Kashimura
Jan 9, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·W Y KimD-S Bae
Mar 23, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G G MaloufP Pautier
Aug 11, 2011·International Journal of Clinical Oncology·Mika MizunoToru Nakanishi
Nov 29, 2005·Archives of Gynecology and Obstetrics·S M LenhardI Bauerfeind
Jul 17, 2012·Acta Oncologica·Claes G TropéGunnar B Kristensen
Mar 12, 2015·Experimental and Molecular Pathology·Karin FlickerFarid Moinfar
Jul 26, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Sagus Sampath, David K Gaffney
Jul 15, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Martee L Hensley
Jul 15, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Ka Yu TseHextan Y S Ngan
Jul 19, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Angiolo Gadducci
Jan 21, 2011·European Journal of Radiology·Beatrice M Seddon, Reena Davda
Nov 13, 2010·Surgical Oncology·Leonardo Moura BatistaMarcos Tatagiba
Dec 1, 2009·Surgical Pathology Clinics·Esther Oliva, Patricia M Baker
Oct 27, 2009·Gynecologic Oncology·Emanuela D'Angelo, Jaime Prat
Feb 27, 2007·Gynecologic Oncology·Charles A LeathMichael A Gold
Jan 31, 2006·Cancer Science·Kazumi YamadaMasayuki Noguchi
Sep 5, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Suhail Al-SalamSaad Ghazal-Aswad
Dec 18, 2012·Histopathology·Sarah Chiang, Esther Oliva
Feb 22, 2013·Histopathology·Weiwei FengJan P A Baak
Jul 8, 2011·The Journal of Obstetrics and Gynaecology Research·Panagiotis TsikourasAlexander Tobias Teichmann
Feb 27, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyung Ho YangSeong Yoon Yi
Mar 17, 2007·Pathology·Farid MoinfarFattaneh A Tavassoli
Jul 21, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Mert GolSeyran Yigit
Dec 3, 2005·The Lancet Oncology·Sheetal AcharyaGini F Fleming
Jul 29, 2015·Vascular Specialist International·Mi-Hyeong KimJi-Il Kim
Jan 18, 2015·Journal of Clinical Pathology·Rola H Ali, Marjan Rouzbahman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.